Aspirin and Prostate Cancer Mortality: The Role of Tumor Grading Misclassification
Menée au Danemark auprès de 29 136 patients atteints d'un cancer de la prostate (âge médian : 70 ans, durée médiane de suivi : 4,9 ans), cette étude de cohorte évalue l'association entre l'utilisation d'une faible dose d'aspirine après le diagnostic de la maladie et la mortalité spécifique (7 633 cas)
In their current Annals article, Skriver and colleagues report results from a Danish population-based cohort study estimating prostate cancer–specific survival by aspirin use among 29 136 patients with prostate cancer (1). Aspirin, also known as acetylsalicylic acid, has been linked to a decrease in prostate cancer risk (2) and, in some studies, prostate cancer mortality (2). However, these associations have been controversial; thus, further study is needed.